Abstract

Obesity is a major risk for patients with chronic metabolic disorders including type 2 diabetes. Sonic hedgehog (Shh) is a morphogen that regulates the pancreas and adipose tissue formation during embryonic development. Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor superfamily and one of the most important regulators of insulin action. Here, we evaluated the role and mechanism of Shh signaling in obesity-associated insulin resistance and characterized its effect on PPARγ. We showed that Shh expression was up-regulated in subcutaneous fat from obese mice. In differentiated 3T3-L1 and primary cultured adipocytes from rats, recombinant Shh protein and SAG (an agonist of Shh signaling) activated an extracellular signal-regulated kinase (ERK)-dependent noncanonical pathway and induced PPARγ phosphorylation at serine 112, which decreased PPARγ activity. Meanwhile, Shh signaling degraded PPARγ protein via binding of PPARγ to neural precursor cell-expressed developmentally down-regulated protein 4-1 (NEDD4-1). Furthermore, vismodegib, an inhibitor of Shh signaling, attenuated ERK phosphorylation induced by a high fat diet (HFD) and restored PPARγ protein level, thus ameliorating glucose intolerance and insulin resistance in obese mice. Our finding suggests that Shh in subcutaneous fat decreases PPARγ activity and stability via activation of an ERK-dependent noncanonical pathway, resulting in impaired insulin action. Inhibition of Shh may serve as a potential therapeutic approach to treat obesity-related diabetes.

Highlights

  • Obesity is a major risk for patients with chronic metabolic disorders including type 2 diabetes

  • To determine whether Hh ligands are implicated in obesity, C57Bl/6 mice were first fed with a high fat diet (HFD) for 12 weeks

  • We measured the expressions of Sonic hedgehog (Shh), Indian hedgehog (Ihh), and Desert hedgehog (Dhh) in subcutaneous, epididymal and brown adipose tissues

Read more

Summary

ARTICLE cro

Sonic hedgehog signaling instigates high-fat diet–induced insulin resistance by targeting PPAR␥ stability. We evaluated the role and mechanism of Shh signaling in obesity-associated insulin resistance and characterized its effect on PPAR␥. Vismodegib, an inhibitor of Shh signaling, attenuated ERK phosphorylation induced by a high fat diet (HFD) and restored PPAR␥ protein level, ameliorating glucose intolerance and insulin resistance in obese mice. Our finding suggests that Shh in subcutaneous fat decreases PPAR␥ activity and stability via activation of an ERK-dependent noncanonical pathway, resulting in impaired insulin action. Tel.: 86-0411-86110233; Fax: 86-0411-86118981; E-mail: nanpingwang2003@ yahoo.com We demonstrate that Shh in subcutaneous adipose tissue decreases the activity and stability of PPAR␥ by activating the ERK-dependent noncanonical pathway. Vismodegib, an inhibitor of Shh signaling, improves obesity-related insulin resistance by stabilizing PPAR␥

Shh is induced in subcutaneous adipose tissue from obese mice
Vismodegib improves insulin sensitivity in obese mice induced by a HFD
Discussion
Animal procedures
Experimental procedures
Glucose tolerance test and insulin tolerance test
Statistical analyses
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call